How many clinical trials are studying CD19 CAR-T cells?

4 recruiting trials in our tracked data involve CD19 CAR-T cells.

What conditions is CD19 CAR-T cells being studied for?

In our tracked recruiting trials, CD19 CAR-T cells is being studied in trials for Lupus, Systemic Lupus Erythematosus, Lupus Nephritis (LN).

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 4 Phase 2 1

Condition	Trials
Lupus · CD19 CAR-T cells for Lupus	4
Systemic Lupus Erythematosus	2
Lupus Nephritis (LN)	1
Systemic Lupus Erythematosus (SLE)	1
Systemic Lupus Erythematous (SLE)	1

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
NCT06585514 · Phase: Phase 1, Phase 2 · Ages: 3 Years to 65 Years · Sex: All (male and female) · 1 location
Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
NCT06710717 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07331467 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07233642 · Phase: Phase 1 · Ages: 5 Years and older · Sex: All (male and female) · 1 location